Clinical Trials List
2016-09-01 - 2020-12-31
Phase III
Terminated5
ICD-10C67
Malignant neoplasm of bladder
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- - - Division of Urology
- Chia-Chi Lin Division of Hematology & Oncology
- Yeong-Shiau Pu Division of Urology
- JHE-CYUAN GUO Division of Hematology & Oncology
- Yu-Chieh Tsai Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Urology
- YU-CHUAN LU Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- Chueh-Chuan Yen Division of Radiation Therapy
- Tzu-Ping Lin Division of Urology
- Hsiao-Jen Chung Division of Urology
- Tzeon-jye Chiou Division of Hematology & Oncology
- 潘競成 Division of General Surgery
- Yen-Hwa Chang Division of Urology
- Jin-Hwang Liu Division of Hematology & Oncology
- 沈書慧 Division of Radiology
- Tzu-chun Wei Division of Urology
- Mu-Hsin Chang Division of Radiation Therapy
The Actual Total Number of Participants Enrolled
10 Terminated
Audit
None
Co-Principal Investigator
- Shang-Yin Wu Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Co-Principal Investigator
- 陳彥仰 Division of Hematology & Oncology
- 陳彥豪 Division of Hematology & Oncology
- 劉建廷 Division of Hematology & Oncology
- Tai-Jan Chiu Division of Hematology & Oncology
- Shau-Hsuan Li Division of Hematology & Oncology
- 吳佳哲 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Taiwan National PI
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
990 participants
